chapter 38/39: anti-neoplastic Flashcards

1
Q

what is the clinical application of Gefitinib

A

non-small cell lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are some adverse reactions seen with Gefitinib

A

interstitial lung disease, corneal erosion; rash, diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the mechanism of action of Gefitinib

A

reversible inhibitor of the EGFR (ErbB1) cytoplasmic tyrosine kinase domain; competes with ATP binding to the kinase domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

who has the most favorable response to Gefitinib

A

patients with bronchoalveolar cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the clinical application of Erlotinib

A

non-small cell lung cancer; carcinoma of pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are some adverse rxns seen with Erlotinib

A

MI, DVT, microangiopathic hemolytic anemia, elevated liver enzymes, stroke, conjunctivitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the mechanism of action of Erlotinib

A

reversible inhibitor of EGFR (ErbB1) cytoplasmic tyrosine kinase domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the clinical application of cetuximab

A

colorectal cancer; head and neck cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are some adverse reactions seen with cetuximab

A

cardiac arrest, Pulmonary embolism, rash, diarrhea, hypomagnesemia, asthenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the mechanism of action of cetuximab

A

monoclonal IgG antibody that binds to extracellular domain EGFR (ErbB1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

development of what is predictive of tumor response when cetuximab is used

A

development of rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the clinical application of trastuzumab

A

breast cancer or metastatic gastric caner with HER2 over expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are some adverse reactions seen with trastuzumab

A

cardiotoxicity, nephrotic syndrome, leukopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the mechanism of action of trastuzumab

A

monoclonal IgG antibody against ErbB2 (HER2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the clinical application of imatinib

A

CML expression the philadelphia chromosome; GI stroll tumor GIST expressing Kit (CD117); idiopathic hypereosinophilic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are some adverse reactions see with imatinib

A

edema, myelosuppresion, nausea, muscle cramps, diarrhea, rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the mechanism of action of sorafenib

A

inhibits both wild type and mutant B-RAF (RAS/MAP kinase pathway inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the mechanism of action of rapamycin (sirolimus)

A

inhibits mTor but also blocks downstream targets of mTOR such as cyclin D1, c-MYC, BAD, and Hif-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the mechanism of action of bortezomib

A

inhibits an active site N-terminal threonine residue within the 20S catalytic subunit of the proteasome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the clinical application of sorafenib

A

renal cell carcinoma, hepatocellular carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is the clinical application of rapamycin (sirolimus)

A

prophylaxis for renal transplant rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the clinical application of bortezomib

A

multiple myeloma; mantle cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are some adverse effects seen with sorafenib

A

CV disease, erythema multiform, hand-foot rash, elevated lipase and amylase levels; depressed blood cell counts; neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what are some adverse effects seen with rapamycin (sirolimus)

A

increased susceptibility to infection, lymphoma, malignancy; thrombotic microangiopathy; renal toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
what are some adverse effects seen with bortezomib
HF, neutropenia, thrombocytopenia, neuropathy, hypotension, arthralgia
26
what else does sorafenib inhibit besides B-RAF
VEGFR-2, PDGFR-2
27
what drugs should be avoided when using rapamycin (sirolimus)
drugs that induce or inhibit CYP 450
28
what is the clinical application of bevacizumab
metastatic colorectal cancer; non-small cell lung cancer
29
what are some adverse reactions seen with bevacizumab
arterial thromboembolism; hypertensive crisis; nephrotic syndrome
30
what is the mechanism of action of bevacizumab
monoclonal IgG1 antibody against VEFF-A
31
what is the clinical application of sunitinib
renal cell carcinoma; GI stromal tumor
32
what is the clinical application of thalidomide
multiple myeloma; erythema nodosum leprosum
33
what is the clinical application of lenalidomide
multiple myeloma; myelodysplastic syndrome
34
what are some adverse effects seen with sunitinib
left ventricular dysfunction, anemia; hepatotoxicity; inflammation of mucous membrane; thyroid dysfunction
35
what is the mechanism of action of sunitinib
inhibits VEGFR-1, VEGFR-2, PDGFR, and other receptor tyrosine kinases
36
what are some adverse effects seen with thalidomide
teratogenesis, thrombotic disorder, SJS; peripheral neuropathy
37
what are some contraindications for thalidomide use
pregnancy; women capable of becoming pregnant; males not using latex condom
38
what is the mechanism of action of thalidomide
inhibits basic fibroblast growth factor (bFGF)-induced angiogenesis; also costimulates T cells
39
what is thalidomide used in combination with as first line regimen for multiple myeloma
dexamethasone
40
what are some adverse effects seen with rituximab
significant immunosuppression; anaphylactoid reaction related to chimeric antibodies; hematologic abnormalities; infusion reactions
41
what is the mechanism of action of lenalidomide
analogue of thalidomide with enhanced inhibition of TNF-alpha and improved T-cell costimulatory properties, while maintaining antiangiogenic activity
42
what is the mechanism of action of rituximab
anti-CD20 antibody
43
what is the clinical application of fluorouracil (5-FU)
breast cancer, GI cancers, skin cancer (topical application)
44
what are some adverse reactions seen with fluorouracil
coronary atherosclerosis, cerebellar syndrome, visual changes, stenosis of lacrimal system; photosensitivity
45
what are some contraindications to fluorouracil use
severe bone marrow depression, poor nutritional state, serious infection, dihydropyrmidine dehydrogenase deficiency, pregnancy
46
what is the mechanism of action of fluorouracil
inhibits thymidylate synthase by binding to the deoxyuridylate (substrate) site on the enzyme
47
what can be used to potentiate the action of fluorouracil
folinic acid
48
what is the clinical application of capecitabine
metastatic colorectal cancer; breast cancer
49
what are the contraindications to capecitabine use
dihydropyrimidine dehydrogenase deficiency; severe renal impairment
50
what is the orally available prodrug for of 5-FU
capecitabine
51
what is the mechanism of action of 6-mercaptopurine (6-MP) and azathioprine
inhibits IMPDH and other synthetic enzymes, thereby interfering with AMP and GMP synthesis
52
what is the main clinical application of 6-mercaptopurine
acute lymphoblastic leukemia
53
what are the clinical applications of azathioprine
immunosuppression in renal transplantation, rheumatoid arthritis, IBD
54
what are some adverse reactions seen with 6-mercaptopurine (6-MP) and azathioprine
pancreatitis, myelosuppresion, hepatotoxicity, infection; gastritis
55
what is a contraindication for 6-mercaptopurine (6-MP) and azathioprine
pregnancy
56
what is the mechanism of action of hydroxyurea
inhibit ribonucleotide reductase (enzyme that converts ribonucleotides to deoxyribonucleotides)
57
what are the clinical applications of hydroxyurea
myeloproliferative disorders, hematologic malignancies, head/neck cancers, melanoma, ovarian carcinoma; sickle cell anemia (adults only)
58
what are some adverse reactions seen with hydroxyurea
secondary leukemia with long term use; GI toxicity; skin ulcer
59
what is a contraindication for hydroxyurea use
severe bone marrow depression
60
what is the mechanism of action of thioguanine
incorporation into DNA and RNA results in inhibition of DNA polymerase, thereby causing cell death
61
what is the clinical application of thioguanine
acute myelogenous leukemia
62
what are some adverse reactions seen with thioguanine
hyperuricemia, intestinal perforation, hepatotoxicity
63
what analogue is cladribine
adenosine
64
what is the clinical application of cladribine
hairy cell leukemia, multiple sclerosis
65
what are some adverse reactions seen with cladribine
febrile neutropenia, neurotoxicity
66
what analogue is cytarabine
cytidine
67
what are the clinical applications of cytarabine
acute lymphoblastic and myelogenous leukemia; CML; meningeal leukemia; hodgkin's disease; non-hodgkin lymphoma
68
what are some adverse reactions seen with cytarabine
neuropathy, nephrotoxicity, liver dysfunction; ulcers of mouth and anus
69
what is the mechanism of action of cyclophosphamide
covalently bind DNA, often cross-like to DNA or associated proteins
70
what are the clinical applications of cyclophosphamide
autoimmune diseases, leukemias & lymphomas; advanced mycosis fungoides; neuroblastoma; ovarian cancer; retinoblastoma; malignant histiocytosis
71
what are some adverse reactions seen with cyclophosphamide
cardiomyopathy, SJS, hemorrhagic cystitis, azoospermia, alopecia, amenorrhea
72
what is a contraindication for cyclophosphamide use
severely depressed bone marrow function
73
what metabolite of cyclophosphamide can cause hemorrhagic cystitis and how can it be prevented
acrolein; prevented with co-administration of meson
74
what is the clinical application of mitomycin
gastric pancreatic cancer
75
what is the clinical application of thiotepa
bladder cancer
76
what is the clinical application of carmustine
brain cancer
77
what is the clinical application of dacarbazine
hodgkins disease
78
what is the clinical application mom procarbazine
hodgkins disease
79
what is the clinical application of altretamine
ovarian cancer
80
what is a contraindication for mitomycin use
coagulation disorder or renal impairment
81
what is a contraindication for thiotepa use
hepatic, renal or bone marrow dysfunction
82
what is a alkylating antibiotic that targets hypoxic tumor cells
mitomycin
83
what is the mechanism of action of cisplatin and carboplatin
cross-link intrastrand guanine bases
84
what is the clinical application of cisplatin and carboplatin
genitourinary cancers; lung cancers
85
what is the dose limiting toxicity of cisplatin
nephrotoxicity
86
what are some contraindications for cisplatin and carboplatin use
severe bone marrow depression; renal/hearing impairment
87
what can be co-administered with cisplatin to limit nephrotoxicity
amifostine
88
what is the mechanism of action of bleomycin
binds oxygen and chelates Fe(II); binds DNA and leads to strand breaks via generation of oxidative intermediates
89
what is the clinical application of bleomycin
testicular cancer; hodgkin disease
90
what is the dose-limiting toxicity of bleomycin
pulmonary fibrosis
91
what is the clinical application of irinotecan
colorectal cancer
92
what is the clinical application of topotecan
small cell lung cancer, cervical carcinoma, ovarian cancer
93
what are some adverse reactions seen with irinotecan and topotecan
life-threatening diarrhea, febrile neutropenia, alopecia, eosinophilia
94
what stage in the cell cycle are irinotecan and topotecan specific for and what do they inhibit
S phase; inhibit topoisomerase 1
95
what are the clinical applications of doxorubicin
leukemias, lymphomas, breast cancer, bladder cancer, thyroid cancer, GI cancer, nephroblastoma, osteosarcoma, ovarian cancer, small cell lung cancer; soft tissue sarcoma
96
what is a major adverse reaction seen with doxorubicin
heart failure
97
what are some contraindications for doxorubicin
preexisting heart failure, severe bone marrow depression
98
what does doxorubicin inhibit and what stage of the cell cycle does it target
inhibits topoisomerase 2; G2 phase
99
what is the clinical application of etoposide
testicular and lung cancer; leukemia
100
what does etoposide inhibit and what stage of the cell cycle does it target
inhibits topoisomerase 2; action is specific to late S phase and G2 phases
101
what is the mechanism of action of vinblastine
bind tubular subunits and prevent microtubule polymerization
102
what are some adverse reactions seen with vinblastine
myelosuppresion, azoospermia, alopecia, bone pain
103
what are some contraindications for vinblastine use
bacterial infection; significant granulocytopenia
104
what is the dose-limiting toxicity of vinblastine
bone marrow suppression
105
what are some contraindications for vincristine use
charcot-marie-tooth syndrome; intrathecal use
106
what is the dose limiting effect of vincristine
peripheral neuropathy
107
what agent that inhibits microtubule polymerization can lead to diplopia as an adverse effect
vincristine
108
what is the dose limiting toxicity of paclitaxel
peripheral neuropathy
109
what is the clinical application of paclitaxel
ovarian cancer, non-small cell lung cancer; AIDS-related kaposis sarcoma
110
what are the most common clinical uses for docetaxel
breast cancer; non-small cell lung cancer
111
what is the dose limiting toxicity of docetaxel
myelosuppression